BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• October
• November
• December

Day

• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• BioForest

  Bill Gates Pledges $258 Million To Fight Malaria

  October 31, 2005

   · 

  1 min read
• Protox Therapeutics Inc. Announces $4.0 Million Equity Financing

  October 31, 2005

   · 

  1 min read
• FDA

  Savient Pharmaceuticals, Inc. Receives FDA Approval To Market Soltamox(R); The First Oral Liquid Tamoxifen In U.S.; U.K.-Based Liquids Manufacturing Facility Meets The FDA’s Current Good Manufacturing Practices

  October 31, 2005

   · 

  5 min read
• Drug Development

  Microbia, Inc. Presents Results From Phase 1 Trial Demonstrating Md-1100 Is Active And Well-Tolerated In Healthy Volunteers

  October 31, 2005

   · 

  3 min read
• Policy

  Pioneer Hi-Bred International, Inc. Release: DuPont Statement On Final Regulatory Approval Of The Herculex(R) XTRA

  October 31, 2005

   · 

  2 min read
• Business

  Merck & Co., Inc. And Bristol-Myers Squibb Company License New AIDS Drugs To International Partnership for Microbicides (IPM) For Development As Microbicides To Protect Women From HIV

  October 31, 2005

   · 

  7 min read
• Business

  Metabolex, Inc. Appoints Paul Quinlan As General Counsel

  October 31, 2005

   · 

  2 min read
• Biotech Bay

  Exelixis, Inc. Announces November 7 Webcast Of Presentation At The CIBC 16th Annual Healthcare Conference

  October 31, 2005

   · 

  2 min read
• Biotech Bay

  Exelixis, Inc. Announces November 9 Webcast Of Presentation At The SG Cowen & Co. 6th Annual Global Healthcare Conference

  October 31, 2005

   · 

  2 min read
• Drug Development

  Dendreon Corporation’s Second Randomized Phase 3 D9902A Trial Of PROVENGE Extends Survival In Patients With Advanced Prostate Cancer

  October 31, 2005

   · 

  7 min read